Form 8-K - Current report:
SEC Accession No. 0001683168-25-000479
Filing Date
2025-01-22
Accepted
2025-01-22 15:47:43
Documents
14
Period of Report
2024-12-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT cannabis_8k.htm   iXBRL 8-K 25684
2 STOCK PURCHASE AGREEMENT cannabis_ex1001.htm EX-10.1 103681
  Complete submission text file 0001683168-25-000479.txt   326530

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cbih-20241227.xsd EX-101.SCH 3003
4 XBRL LABEL FILE cbih-20241227_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE cbih-20241227_pre.xml EX-101.PRE 24157
16 EXTRACTED XBRL INSTANCE DOCUMENT cannabis_8k_htm.xml XML 3489
Mailing Address 6201 BONHOMME ROAD SUITE 435S HOUSTON TX 77036
Business Address 6201 BONHOMME ROAD SUITE 435S HOUSTON TX 77036 214-733-0868
Cannabis Bioscience International Holdings, Inc. (Filer) CIK: 0001411057 (see all company filings)

EIN.: 844901229 | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 333-146758 | Film No.: 25545789
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)